It will be 3 years next month since mention of Fruitflow based products into the Chinese market. , In April 2017 the Company announced that it had entered into a memorandum of understanding with BY-HEALTH Co., Ltd ('BY-HEALTH') which is intended to result in a research and collaboration agreement with BY-HEALTH for Fruitflow®. The Company also confirmed separately that Provexis and DSM are working with BY-HEALTH to support the planned launch of some Fruitflow® based products in the Chinese market.”
To be fair to DSM they do seem to pay a decent multiple of profit for the companies they have bought out , let’s hope the“substantial multiple of existing Fruitflow sales “ Materialises this year .
Thanks Gixer , looks like things are going to change over the next 12-15 months , my guess is a DSM t/o , I think DSM increased there holding in the recent placing , I might be wrong on that .
This doesn’t add up either , Dawson Buck is shown as holding 25, million shares before the latest placing ,then after buying 1,666667 shares in the placing , now shown as holding 30 m. , a Math not great but even I can see that doesn’t add up , did he buy more in the first placing and it hasn’t shown up yet ! https://www.lse.co.uk/DirectorsDeals.asp?shareprice=PXS&share=Provexis